You are here: Industry Insights > Roche

News List

Roche achieves two major milestones in the evolution of decision support platform biospace
March 05, 2018
Roche (SIX: RO, ROG; OTCQX:RHHBY), announces today two major milestones in the evolution of the Decision Support platform being developed in its Diagnostics Information Solutions (DIS) business.
Ionis and Roche Tout Positive Data in Early-Stage Huntington’s Disease Trial biospace
March 05, 2018
Three months ago Roche forked over a payment of $45 million for rights to Ionis Pharmaceuticals, Inc. investigational drug IONIS-HTTRx for the treatment of Huntington’s disease.
Cipla ties up with Roche to sell 2 key drugs in India financialexpress
March 01, 2018
Roche will be able to focus on bringing new, transformative medicines to patients in India
Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthroug worldpharmanews
February 28, 2018
Roche and Flatiron Health, Inc. announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health.
Roche reports good results in 2017 worldpharmanews
February 06, 2018
In 2017, Roche Group sales rose 5% to CHF 53.3 billion.
Roche Throws in the Towel on a Host of Early, Late-Stage Drug Candidates biospace
February 02, 2018
In September 2017, Roche’s Phase III eye drug lampalizumab failed to meet endpoints as a treatment for geographic atrophy (GA) due to age-related macular degeneration (AMD)
Roche’s balovaptan obtains FDA breakthrough therapy designation pharmaceutical-technology
January 31, 2018
Roche has obtained breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational drug balovaptan to treat patients with autism spectrum disorder (ASD).
FDA Calls Roche's Autism Drug a Breakthrough biospace
January 30, 2018
An experimental Roche drug designed to improve social interaction in people with autism scored the U.S. Food and Drug Administration’s Breakthrough Therapy Designation.
MSD’s interim Keytruda combo data spooks Roche and BMS pharmafile
January 17, 2018
When PD-1/L1 treatments first came on the market, there was a race to snaffle as many indications as possible for the therapies
Roche's Star MS Drug Snags EU Approval biospace
January 15, 2018
Roche’s OCREVUS (ocrelizumab) approved in the European Union for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page